Search
2025 Volume 42
Article Contents
EDITORIAL   Open Access    

Advancing visual neuroscience: expanding boundaries from bench to bedside

More Information
  • 加载中
  • [1] Peters B, Kriegeskorte N. 2021. Capturing the objects of vision with neural networks. Nature Human Behaviour 5:1127−44 doi: 10.1038/s41562-021-01194-6

    CrossRef   Google Scholar

    [2] Kay K, Bonnen K, Denison RN, Arcaro MJ, Barack DL. 2023. Tasks and their role in visual neuroscience. Neuron 111:1697−713 doi: 10.1016/j.neuron.2023.03.022

    CrossRef   Google Scholar

    [3] Li S, Qiu Y, Li Y, Wu J, Yin N, et al. 2024. Serum metabolite biomarkers for the early diagnosis and monitoring of age-related macular degeneration. Journal of Advanced Research In press doi: 10.1016/j.jare.2024.10.001

    CrossRef   Google Scholar

    [4] Rejas-González R, Montero-Calle A, Pastora Salvador N, Crespo Carballés MJ, Ausín-González E, et al. 2024. Unraveling the nexus of oxidative stress, ocular diseases, and small extracellular vesicles to identify novel glaucoma biomarkers through in-depth proteomics. Redox Biol 77:103368 doi: 10.1016/j.redox.2024.103368

    CrossRef   Google Scholar

    [5] Goltstein PM. 2022. Visual neuroscience: A shrewd look at perceptual learning. Current Biology 32:R839−R841 doi: 10.1016/j.cub.2022.07.002

    CrossRef   Google Scholar

    [6] Hanson RLW, Baseler HA, Airody A, Morland AB, Gale RP. 2022. Cortical atrophy predicts visual performance in long-term central retinal disease; GCL, pRNFL and cortical thickness are key biomarkers. Investigative Ophthalmology & Visual Science 63:35 doi: 10.1167/iovs.63.5.35

    CrossRef   Google Scholar

    [7] Farjood F, Manos JD, Wang Y, Williams AL, Zhao C, et al. 2023. Identifying biomarkers of heterogeneity and transplantation efficacy in retinal pigment epithelial cells. Journal of Experimental Medicine 220:e20230913 doi: 10.1084/jem.20230913

    CrossRef   Google Scholar

    [8] Li Z, Wang L, Wu X, Jiang J, Qiang W, et al. 2023. Artificial intelligence in ophthalmology: The path to the real-world clinic. Cell Reports Medicine 4:101095 doi: 10.1016/j.xcrm.2023.101095

    CrossRef   Google Scholar

    [9] Hwang S, Kang SW, Kim SJ, Han K, Kim BS, et al. 2023. Impact of Age-Related Macular Degeneration and Related Visual Disability on the Risk of Depression: A Nationwide Cohort Study. Ophthalmology 130:615−23 doi: 10.1016/j.ophtha.2023.01.014

    CrossRef   Google Scholar

    [10] Tsotsos JK, Abid O, Kotseruba I, Solbach MD. 2021. On the control of attentional processes in vision. Cortex 137:305−29 doi: 10.1016/j.cortex.2021.01.001

    CrossRef   Google Scholar

    [11] Sampson DM, Dubis AM, Chen FK, Zawadzki RJ, Sampson DD. 2022. Towards standardizing retinal optical coherence tomography angiography: a review. Light: Science & Applications 11:63 doi: 10.1038/s41377-022-00740-9

    CrossRef   Google Scholar

    [12] Majidi SP, Rajagopal R. 2020. Photoreceptor responses to light in the pathogenesis of diabetic retinopathy. Visual Neuroscience 37:E007 doi: 10.1017/S0952523820000061

    CrossRef   Google Scholar

    [13] Tan TF, Thirunavukarasu AJ, Jin L, Lim J, Poh S, et al. 2023. Artificial intelligence and digital health in global eye health: opportunities and challenges. Lancet Global Health 11:E1432−E1443 doi: 10.1016/S2214-109X(23)00323-6

    CrossRef   Google Scholar

    [14] Welchman AE, Kourtzi ZOE. 2013. Linking brain imaging signals to visual perception. Visual Neuroscience 30:229−41 doi: 10.1017/S0952523813000436

    CrossRef   Google Scholar

  • Cite this article

    Yu H. 2025. Advancing visual neuroscience: expanding boundaries from bench to bedside. Visual Neuroscience 42: e001 doi: 10.48130/vns-0024-0001
    Yu H. 2025. Advancing visual neuroscience: expanding boundaries from bench to bedside. Visual Neuroscience 42: e001 doi: 10.48130/vns-0024-0001

Figures(1)

Article Metrics

Article views(2911) PDF downloads(373)

Other Articles By Authors

EDITORIAL   Open Access    

Advancing visual neuroscience: expanding boundaries from bench to bedside

Visual Neuroscience  42 Article number: e001  (2025)  |  Cite this article
  • Visual perception is a complex neural process that involves interactions between the eyes, optic nerves, and the visual cortex of the brain. As such, visual neuroscience is crucial for understanding the neural mechanisms underlying vision and how the brain processes visual information. This field of study not only has significant implications for diagnosing and treating visual disorders, but also holds promise for developing innovative therapies aimed at restoring or enhancing vision[1,2]. Therefore, advancements in visual neuroscience will further deepen our understanding of the complex collaborative mechanisms between the brain and eyes, ultimately paving the way for earlier diagnosis and more effective treatment of visual diseases.

    The current research in visual neuroscience covers a wide range of experimental and clinical studies focused on the biological mechanisms and disease processes affecting vision. Recent advancements have provided deeper insights into the molecular, cellular, and system-level processes underlying both normal and pathological visual function, with a particular emphasis on retinal degeneration, optic neuropathies, and neurodegenerative diseases that affect the visual system[36]. Novel strategies for restoring vision, including gene therapy, retinal implants, and neuroprotective treatments, are being explored to address a wide range of visual disorders[7]. Furthermore, the integration of advanced imaging techniques, computational models, and psychophysics has significantly enhanced our understanding of visual perception and cognition[810]. Last but not least, clinical studies continue to shed light on manifestations of visual neural damage, while simultaneously advancing treatments for visual dysfunction, offering hope for better therapeutic interventions and technologies.

    Despite huge advances in visual neuroscience, there's still much to explore. Due to the need for transformation between basic theoretical research and clinical application, many potential therapeutic approaches have not been applied to clinical practice in a timely manner. In addition, current imaging technologies such as optical coherence tomography angiography and electrophysiology, often fail to capture the complexities of visual processing and disease progression fully[11,12]. Future research should focus on developing more cost-effective technologies combining advances in artificial intelligence (AI), gene therapy, and multi-omics research to create personalized, multi-modal treatment strategies[13,14]. In particular, the intersection of computational neuroscience and machine learning can further promote the development of AI-based assistive technologies for visual impairments (Fig. 1).

    Figure 1. 

    Research areas in Visual Neuroscience.

    To embrace the promise of this fast-growing research discipline, we are excited to relaunch Visual Neuroscience (VNS), a gold open-access international journal devoted to publishing experimental and clinical research on the biology and disease mechanisms of visual neuroscience (www.maxapress.com/vns). A major goal of this journal is to bring together a broad range of studies that showcase the originality and breadth of neuroscience research related to the visual system. VNS mainly publishes research papers, review articles, comments, prospects, and editorials, including but not limited to: (1) Development and validation of imaging biomarkers and clinical guidelines pertinent to the detection, diagnosis, and management of visual diseases and their associated neurological alterations; (2) Advanced investigations into the anatomy of the visual system, visual perception, and related neurological mechanisms, aiming to deepen understanding of visual neuroscience; (3) Exploration and elucidation of molecular, cellular or systems-level processes in normal visual physiology, disease pathogenesis, and omics-phenotype relationships; (4) Development and validation of animal models, preclinical drug studies, and innovations in nanotechnology and regenerative medicine, and other clinically relevant translational research in visual neuroscience. As an open-access, rigorously peer-reviewed journal, it is committed to facilitating the rapid and efficient global dissemination of scientific discoveries and technological advances in the field of visual neuroscience.

    VNS is dedicated to providing exceptional service to both our authors and readers. Each manuscript undergoes a comprehensive evaluation by our editorial team and is reviewed by at least two independent expert reviewers. We are honored to serve the visual neuroscience community and welcome global experts, particularly those from emerging and interdisciplinary fields, to join our Editorial Board. Together, we aim to pool academic knowledge and expertise to further advance research in visual neuroscience.

    • The author declares that there is no conflict of interest.

    • Copyright: © 2025 by the author(s). Published by Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.
Figure (1)  References (14)
  • About this article
    Cite this article
    Yu H. 2025. Advancing visual neuroscience: expanding boundaries from bench to bedside. Visual Neuroscience 42: e001 doi: 10.48130/vns-0024-0001
    Yu H. 2025. Advancing visual neuroscience: expanding boundaries from bench to bedside. Visual Neuroscience 42: e001 doi: 10.48130/vns-0024-0001
  • Catalog

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return